Global Neurotrophins Market Research Report 2020

August 2020 | 90 pages | ID: G8574D797D74EN
QYResearch

Abstracts

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the Neurotrophins market is segmented into

• Nerve Growth Factor
• Brain-Derived Neurotrophic Factor
• Dehydroepiandrosterone Sulfate
• Other

Segment by Application

• Alzheimer'S Disease
• Amyotrophic Lateral Sclerosis
• Parkinson'S Disease
• Other

Global Neurotrophins Market: Regional Analysis
The Neurotrophins market is analysed and market size information is provided by regions (countries).
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.

The key regions covered in the Neurotrophins market report are:

• North America
• U.S.
• Canada
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Asia-Pacific
• China
• Japan
• South Korea
• India
• Australia
• Taiwan
• Indonesia
• Thailand
• Malaysia
• Philippines
• Vietnam
• Latin America
• Mexico
• Brazil
• Argentina
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE

Global Neurotrophins Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
The major players in global Neurotrophins market include:

• Johnson?Johnson
• Lonza Groups
• FibroGen
• Scil Proteins GmbH
• Merck Serono
• Scil Proteins GmbH
• PeproTech
• GE Healthcare

Contents

1 NEUROTROPHINS MARKET OVERVIEW

1.1 Product Overview and Scope of Neurotrophins
1.2 Neurotrophins Segment by Type
  1.2.1 Global Neurotrophins Sales Growth Rate Comparison by Type (2021-2026)
  1.2.2 Nerve Growth Factor
  1.2.3 Brain-Derived Neurotrophic Factor
  1.2.4 Dehydroepiandrosterone Sulfate
  1.2.5 Other
1.3 Neurotrophins Segment by Application
  1.3.1 Neurotrophins Sales Comparison by Application: 2020 VS 2026
  1.3.2 Alzheimer'S Disease
  1.3.3 Amyotrophic Lateral Sclerosis
  1.3.4 Parkinson'S Disease
  1.3.5 Other
1.4 Global Neurotrophins Market Size Estimates and Forecasts
  1.4.1 Global Neurotrophins Revenue 2015-2026
  1.4.2 Global Neurotrophins Sales 2015-2026
  1.4.3 Neurotrophins Market Size by Region: 2020 Versus 2026
1.5 Neurotrophins Industry
1.6 Neurotrophins Market Trends

2 GLOBAL NEUROTROPHINS MARKET COMPETITION BY MANUFACTURERS

2.1 Global Neurotrophins Sales Market Share by Manufacturers (2015-2020)
2.2 Global Neurotrophins Revenue Share by Manufacturers (2015-2020)
2.3 Global Neurotrophins Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Neurotrophins Manufacturing Sites, Area Served, Product Type
2.5 Neurotrophins Market Competitive Situation and Trends
  2.5.1 Neurotrophins Market Concentration Rate
  2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
  2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Neurotrophins Players (Opinion Leaders)

3 NEUROTROPHINS RETROSPECTIVE MARKET SCENARIO BY REGION

3.1 Global Neurotrophins Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Neurotrophins Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Neurotrophins Market Facts & Figures by Country
  3.3.1 North America Neurotrophins Sales by Country
  3.3.2 North America Neurotrophins Sales by Country
  3.3.3 U.S.
  3.3.4 Canada
3.4 Europe Neurotrophins Market Facts & Figures by Country
  3.4.1 Europe Neurotrophins Sales by Country
  3.4.2 Europe Neurotrophins Sales by Country
  3.4.3 Germany
  3.4.4 France
  3.4.5 U.K.
  3.4.6 Italy
  3.4.7 Russia
3.5 Asia Pacific Neurotrophins Market Facts & Figures by Region
  3.5.1 Asia Pacific Neurotrophins Sales by Region
  3.5.2 Asia Pacific Neurotrophins Sales by Region
  3.5.3 China
  3.5.4 Japan
  3.5.5 South Korea
  3.5.6 India
  3.5.7 Australia
  3.5.8 Taiwan
  3.5.9 Indonesia
  3.5.10 Thailand
  3.5.11 Malaysia
  3.5.12 Philippines
  3.5.13 Vietnam
3.6 Latin America Neurotrophins Market Facts & Figures by Country
  3.6.1 Latin America Neurotrophins Sales by Country
  3.6.2 Latin America Neurotrophins Sales by Country
  3.6.3 Mexico
  3.6.3 Brazil
  3.6.3 Argentina
3.7 Middle East and Africa Neurotrophins Market Facts & Figures by Country
  3.7.1 Middle East and Africa Neurotrophins Sales by Country
  3.7.2 Middle East and Africa Neurotrophins Sales by Country
  3.7.3 Turkey
  3.7.4 Saudi Arabia
  3.7.5 UAE

4 GLOBAL NEUROTROPHINS HISTORIC MARKET ANALYSIS BY TYPE

4.1 Global Neurotrophins Sales Market Share by Type (2015-2020)
4.2 Global Neurotrophins Revenue Market Share by Type (2015-2020)
4.3 Global Neurotrophins Price Market Share by Type (2015-2020)
4.4 Global Neurotrophins Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 GLOBAL NEUROTROPHINS HISTORIC MARKET ANALYSIS BY APPLICATION

5.1 Global Neurotrophins Sales Market Share by Application (2015-2020)
5.2 Global Neurotrophins Revenue Market Share by Application (2015-2020)
5.3 Global Neurotrophins Price by Application (2015-2020)

6 COMPANY PROFILES AND KEY FIGURES IN NEUROTROPHINS BUSINESS

6.1 Johnson?Johnson
  6.1.1 Corporation Information
  6.1.2 Johnson?Johnson Description, Business Overview and Total Revenue
  6.1.3 Johnson?Johnson Neurotrophins Sales, Revenue and Gross Margin (2015-2020)
  6.1.4 Johnson?Johnson Products Offered
  6.1.5 Johnson?Johnson Recent Development
6.2 Lonza Groups
  6.2.1 Lonza Groups Corporation Information
  6.2.2 Lonza Groups Description, Business Overview and Total Revenue
  6.2.3 Lonza Groups Neurotrophins Sales, Revenue and Gross Margin (2015-2020)
  6.2.4 Lonza Groups Products Offered
  6.2.5 Lonza Groups Recent Development
6.3 FibroGen
  6.3.1 FibroGen Corporation Information
  6.3.2 FibroGen Description, Business Overview and Total Revenue
  6.3.3 FibroGen Neurotrophins Sales, Revenue and Gross Margin (2015-2020)
  6.3.4 FibroGen Products Offered
  6.3.5 FibroGen Recent Development
6.4 Scil Proteins GmbH
  6.4.1 Scil Proteins GmbH Corporation Information
  6.4.2 Scil Proteins GmbH Description, Business Overview and Total Revenue
  6.4.3 Scil Proteins GmbH Neurotrophins Sales, Revenue and Gross Margin (2015-2020)
  6.4.4 Scil Proteins GmbH Products Offered
  6.4.5 Scil Proteins GmbH Recent Development
6.5 Merck Serono
  6.5.1 Merck Serono Corporation Information
  6.5.2 Merck Serono Description, Business Overview and Total Revenue
  6.5.3 Merck Serono Neurotrophins Sales, Revenue and Gross Margin (2015-2020)
  6.5.4 Merck Serono Products Offered
  6.5.5 Merck Serono Recent Development
6.6 Scil Proteins GmbH
  6.6.1 Scil Proteins GmbH Corporation Information
  6.6.2 Scil Proteins GmbH Description, Business Overview and Total Revenue
  6.6.3 Scil Proteins GmbH Neurotrophins Sales, Revenue and Gross Margin (2015-2020)
  6.6.4 Scil Proteins GmbH Products Offered
  6.6.5 Scil Proteins GmbH Recent Development
6.7 PeproTech
  6.6.1 PeproTech Corporation Information
  6.6.2 PeproTech Description, Business Overview and Total Revenue
  6.6.3 PeproTech Neurotrophins Sales, Revenue and Gross Margin (2015-2020)
  6.4.4 PeproTech Products Offered
  6.7.5 PeproTech Recent Development
6.8 GE Healthcare
  6.8.1 GE Healthcare Corporation Information
  6.8.2 GE Healthcare Description, Business Overview and Total Revenue
  6.8.3 GE Healthcare Neurotrophins Sales, Revenue and Gross Margin (2015-2020)
  6.8.4 GE Healthcare Products Offered
  6.8.5 GE Healthcare Recent Development

7 NEUROTROPHINS MANUFACTURING COST ANALYSIS

7.1 Neurotrophins Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Key Raw Materials Price Trend
  7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Neurotrophins
7.4 Neurotrophins Industrial Chain Analysis

8 MARKETING CHANNEL, DISTRIBUTORS AND CUSTOMERS

8.1 Marketing Channel
8.2 Neurotrophins Distributors List
8.3 Neurotrophins Customers

9 MARKET DYNAMICS

9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis

10 GLOBAL MARKET FORECAST

10.1 Global Neurotrophins Market Estimates and Projections by Type
  10.1.1 Global Forecasted Sales of Neurotrophins by Type (2021-2026)
  10.1.2 Global Forecasted Revenue of Neurotrophins by Type (2021-2026)
10.2 Neurotrophins Market Estimates and Projections by Application
  10.2.1 Global Forecasted Sales of Neurotrophins by Application (2021-2026)
  10.2.2 Global Forecasted Revenue of Neurotrophins by Application (2021-2026)
10.3 Neurotrophins Market Estimates and Projections by Region
  10.3.1 Global Forecasted Sales of Neurotrophins by Region (2021-2026)
  10.3.2 Global Forecasted Revenue of Neurotrophins by Region (2021-2026)
10.4 North America Neurotrophins Estimates and Projections (2021-2026)
10.5 Europe Neurotrophins Estimates and Projections (2021-2026)
10.6 Asia Pacific Neurotrophins Estimates and Projections (2021-2026)
10.7 Latin America Neurotrophins Estimates and Projections (2021-2026)
10.8 Middle East and Africa Neurotrophins Estimates and Projections (2021-2026)

11 RESEARCH FINDING AND CONCLUSION

12 METHODOLOGY AND DATA SOURCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Global Neurotrophins Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Neurotrophins Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Neurotrophins Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Neurotrophins Manufacturers Covered in This Study
Table 5. Global Neurotrophins Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Neurotrophins Sales Share by Manufacturers (2015-2020)
Table 7. Global Neurotrophins Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Neurotrophins Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Neurotrophins Average Price (US$/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Neurotrophins Sales Sites and Area Served
Table 11. Manufacturers Neurotrophins Product Types
Table 12. Global Neurotrophins Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Neurotrophins by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neurotrophins as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Neurotrophins Players
Table 16. Global Neurotrophins Sales (K Units) by Region (2015-2020)
Table 17. Global Neurotrophins Sales Market Share by Region (2015-2020)
Table 18. Global Neurotrophins Revenue (Million US$) by Region (2015-2020)
Table 19. Global Neurotrophins Revenue Market Share by Region (2015-2020)
Table 20. North America Neurotrophins Sales by Country (2015-2020) (K Units)
Table 21. North America Neurotrophins Sales Market Share by Country (2015-2020)
Table 22. North America Neurotrophins Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Neurotrophins Revenue Market Share by Country (2015-2020)
Table 24. Europe Neurotrophins Sales by Country (2015-2020) (K Units)
Table 25. Europe Neurotrophins Sales Market Share by Country (2015-2020)
Table 26. Europe Neurotrophins Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Neurotrophins Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Neurotrophins Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Neurotrophins Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Neurotrophins Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Neurotrophins Revenue Market Share by Region (2015-2020)
Table 32. Latin America Neurotrophins Sales by Country (2015-2020) (K Units)
Table 33. Latin America Neurotrophins Sales Market Share by Country (2015-2020)
Table 34. Latin America Neurotrophins Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Neurotrophins Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Neurotrophins Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Neurotrophins Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Neurotrophins Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Neurotrophins Revenue Market Share by Country (2015-2020)
Table 40. Global Neurotrophins Sales (K Units) by Type (2015-2020)
Table 41. Global Neurotrophins Sales Share by Type (2015-2020)
Table 42. Global Neurotrophins Revenue (Million US$) by Type (2015-2020)
Table 43. Global Neurotrophins Revenue Share by Type (2015-2020)
Table 44. Global Neurotrophins Price (US$/Unit) by Type (2015-2020)
Table 45. Global Neurotrophins Sales (K Units) by Application (2015-2020)
Table 46. Global Neurotrophins Sales Market Share by Application (2015-2020)
Table 47. Global Neurotrophins Sales Growth Rate by Application (2015-2020)
Table 48. Johnson?Johnson Neurotrophins Corporation Information
Table 49. Johnson?Johnson Description and Business Overview
Table 50. Johnson?Johnson Neurotrophins Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 51. Johnson?Johnson Main Product
Table 52. Johnson?Johnson Recent Development
Table 53. Lonza Groups Neurotrophins Corporation Information
Table 54. Lonza Groups Corporation Information
Table 55. Lonza Groups Neurotrophins Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 56. Lonza Groups Main Product
Table 57. Lonza Groups Recent Development
Table 58. FibroGen Neurotrophins Corporation Information
Table 59. FibroGen Corporation Information
Table 60. FibroGen Neurotrophins Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 61. FibroGen Main Product
Table 62. FibroGen Recent Development
Table 63. Scil Proteins GmbH Neurotrophins Corporation Information
Table 64. Scil Proteins GmbH Corporation Information
Table 65. Scil Proteins GmbH Neurotrophins Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 66. Scil Proteins GmbH Main Product
Table 67. Scil Proteins GmbH Recent Development
Table 68. Merck Serono Neurotrophins Corporation Information
Table 69. Merck Serono Corporation Information
Table 70. Merck Serono Neurotrophins Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 71. Merck Serono Main Product
Table 72. Merck Serono Recent Development
Table 73. Scil Proteins GmbH Neurotrophins Corporation Information
Table 74. Scil Proteins GmbH Corporation Information
Table 75. Scil Proteins GmbH Neurotrophins Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 76. Scil Proteins GmbH Main Product
Table 77. Scil Proteins GmbH Recent Development
Table 78. PeproTech Neurotrophins Corporation Information
Table 79. PeproTech Corporation Information
Table 80. PeproTech Neurotrophins Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 81. PeproTech Main Product
Table 82. PeproTech Recent Development
Table 83. GE Healthcare Neurotrophins Corporation Information
Table 84. GE Healthcare Corporation Information
Table 85. GE Healthcare Neurotrophins Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2015-2020)
Table 86. GE Healthcare Main Product
Table 87. GE Healthcare Recent Development
Table 88. Sales Base and Market Concentration Rate of Raw Material
Table 89. Key Suppliers of Raw Materials
Table 90. Neurotrophins Distributors List
Table 91. Neurotrophins Customers List
Table 92. Market Key Trends
Table 93. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 94. Key Challenges
Table 95. Global Neurotrophins Sales (K Units) Forecast by Type (2021-2026)
Table 96. Global Neurotrophins Sales Market Share Forecast by Type (2021-2026)
Table 97. Global Neurotrophins Revenue (Million US$) Forecast by Type (2021-2026)
Table 98. Global Neurotrophins Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 99. Global Neurotrophins Sales (K Units) Forecast by Application (2021-2026)
Table 100. Global Neurotrophins Revenue (Million US$) Forecast by Application (2021-2026)
Table 101. Global Neurotrophins Sales (K Units) Forecast by Region (2021-2026)
Table 102. Global Neurotrophins Sales Market Share Forecast by Region (2021-2026)
Table 103. Global Neurotrophins Revenue Forecast by Region (2021-2026) (US$ Million)
Table 104. Global Neurotrophins Revenue Market Share Forecast by Region (2021-2026)
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Neurotrophins
Figure 2. Global Neurotrophins Sales Market Share by Type: 2020 VS 2026
Figure 3. Nerve Growth Factor Product Picture
Figure 4. Brain-Derived Neurotrophic Factor Product Picture
Figure 5. Dehydroepiandrosterone Sulfate Product Picture
Figure 6. Other Product Picture
Figure 7. Global Neurotrophins Consumption Market Share by Application: 2020 VS 2026
Figure 8. Alzheimer'S Disease
Figure 9. Amyotrophic Lateral Sclerosis
Figure 10. Parkinson'S Disease
Figure 11. Other
Figure 12. Global Neurotrophins Market Size 2015-2026 (US$ Million)
Figure 13. Global Neurotrophins Sales Capacity (K Units) (2015-2026)
Figure 14. Global Neurotrophins Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Neurotrophins Sales Share by Manufacturers in 2020
Figure 16. Global Neurotrophins Revenue Share by Manufacturers in 2019
Figure 17. The Global 5 and 10 Largest Players: Market Share by Neurotrophins Revenue in 2019
Figure 18. Neurotrophins Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Neurotrophins Sales Market Share by Region (2015-2020)
Figure 20. Global Neurotrophins Sales Market Share by Region in 2019
Figure 21. Global Neurotrophins Revenue Market Share by Region (2015-2020)
Figure 22. Global Neurotrophins Revenue Market Share by Region in 2019
Figure 23. North America Neurotrophins Sales Market Share by Country in 2019
Figure 24. North America Neurotrophins Revenue Market Share by Country in 2019
Figure 25. U.S. Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 26. U.S. Neurotrophins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Canada Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 28. Canada Neurotrophins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 29. Europe Neurotrophins Sales Market Share by Country in 2019
Figure 30. Europe Neurotrophins Revenue Market Share by Country in 2019
Figure 31. Germany Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 32. Germany Neurotrophins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. France Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 34. France Neurotrophins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. U.K. Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.K. Neurotrophins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Italy Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 38. Italy Neurotrophins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Russia Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 40. Russia Neurotrophins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Asia Pacific Neurotrophins Sales Market Share by Region in 2019
Figure 42. Asia Pacific Neurotrophins Revenue Market Share by Region in 2019
Figure 43. China Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 44. China Neurotrophins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Japan Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 46. Japan Neurotrophins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. South Korea Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 48. South Korea Neurotrophins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. India Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 50. India Neurotrophins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Australia Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 52. Australia Neurotrophins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Taiwan Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 54. Taiwan Neurotrophins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Indonesia Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 56. Indonesia Neurotrophins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Thailand Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 58. Thailand Neurotrophins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Malaysia Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 60. Malaysia Neurotrophins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Philippines Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 62. Philippines Neurotrophins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Vietnam Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 64. Vietnam Neurotrophins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Latin America Neurotrophins Sales Market Share by Country in 2019
Figure 66. Latin America Neurotrophins Revenue Market Share by Country in 2019
Figure 67. Mexico Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 68. Mexico Neurotrophins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Brazil Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 70. Brazil Neurotrophins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Argentina Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 72. Argentina Neurotrophins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Middle East and Africa Neurotrophins Sales Market Share by Country in 2019
Figure 74. Middle East and Africa Neurotrophins Revenue Market Share by Country in 2019
Figure 75. Turkey Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 76. Turkey Neurotrophins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Saudi Arabia Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 78. Saudi Arabia Neurotrophins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. UAE Neurotrophins Sales Growth Rate (2015-2020) (K Units)
Figure 80. UAE Neurotrophins Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Sales Market Share of Neurotrophins by Type (2015-2020)
Figure 82. Sales Market Share of Neurotrophins by Type in 2019
Figure 83. Revenue Share of Neurotrophins by Type (2015-2020)
Figure 84. Revenue Market Share of Neurotrophins by Type in 2019
Figure 85. Global Neurotrophins Sales Growth by Type (2015-2020) (K Units)
Figure 86. Global Neurotrophins Sales Market Share by Application (2015-2020)
Figure 87. Global Neurotrophins Sales Market Share by Application in 2019
Figure 88. Global Revenue Share of Neurotrophins by Application (2015-2020)
Figure 89. Global Revenue Share of Neurotrophins by Application in 2020
Figure 90. Johnson?Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Lonza Groups Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. FibroGen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Scil Proteins GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Merck Serono Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Scil Proteins GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. PeproTech Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Price Trend of Key Raw Materials
Figure 99. Manufacturing Cost Structure of Neurotrophins
Figure 100. Manufacturing Process Analysis of Neurotrophins
Figure 101. Neurotrophins Industrial Chain Analysis
Figure 102. Channels of Distribution
Figure 103. Distributors Profiles
Figure 104. Porter's Five Forces Analysis
Figure 105. North America Neurotrophins Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 106. North America Neurotrophins Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Europe Neurotrophins Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 108. Europe Neurotrophins Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Latin America Neurotrophins Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 110. Latin America Neurotrophins Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Middle East and Africa Neurotrophins Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 112. Middle East and Africa Neurotrophins Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Asia Pacific Neurotrophins Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 114. Asia Pacific Neurotrophins Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Bottom-up and Top-down Approaches for This Report
Figure 116. Data Triangulation
Figure 117. Key Executives Interviewed